Conjunctival Myofibrosarcoma Managed with Multiple Applications of Episcleral Brachytherapy

A 54-year-old man on immunosuppressant therapy after a renal transplant two years before presented at Cole Eye Institute with a recurrent ocular surface tumor. After five years, the patient’s final visual acuity is 20/20 without evidence of local recurrence, radiation retinopathy or optic neuropathy. To our knowledge, this is the first reported case of primary ocular or conjunctival myofibrosarcoma.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy